Administration of a 'Thirst Relieve Kit' Versus Placebo in Patients After Hospital-based Bowel Preparation for Colonoscopy and Assessment of Thirst Intensity
1 other identifier
interventional
158
1 country
1
Brief Summary
The goal of this study is to evaluate whether a "thirst kit" (lemon popsicle) is effective in reducing thirst intensity in patients undergoing hospital bowel preparation for colonoscopy. The study also aims to assess the impact of the thirst kit on associated symptoms and patient satisfaction. The main questions it aims to answer are:
- Does the thirst kit reduce the intensity of thirst after bowel preparation for colonoscopy?
- Does the thirst kit reduce symptoms such as dry mouth and dry throat?
- How satisfied are patients when using the thirst kit compared to a placebo? Researchers will compare the thirst kit to a placebo to determine its effectiveness in managing thirst during the pre-colonoscopy period. Participants will:
- Be randomly assigned to receive either the thirst kit (lemon popsicle) or a placebo
- Use the assigned intervention during the hospital preparation period for colonoscopy
- Rate thirst intensity, associated symptoms, and satisfaction using numerical scales
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 8, 2025
CompletedFirst Submitted
Initial submission to the registry
April 7, 2026
CompletedFirst Posted
Study publicly available on registry
July 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 12, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
July 13, 2026
March 1, 2026
8 months
April 7, 2026
July 7, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
The primary outcome of the study is the intensity of thirst, assessed using a numerical scale (0-10) after administration of the thirst kit or placebo.
The intensity of thirst, measured using a numerical scale from 0 to 10, was assessed after administration of the thirst kit or placebo in patients undergoing hospital preparation for colonoscopy.
10 minutes before the sedation for the exam starts (when the patient arrives in the examination room)
Study Arms (2)
Intervention
EXPERIMENTALGroup lemon popsicle: Group that will receive the lemon popsicle
Placebo
PLACEBO COMPARATORGroup placebo: Group that will recive de placebo (water blister)
Interventions
The intervention group receives a "Thirst relife kit A" consisting of an encouraging message and a 60g lemon-flavored popsicle from the Jundiá® brand (Ingredients: water, sugar, glucose syrup, concentrated lemon juice, citric acid, thickeners, artificial flavoring).
The control group receives a "Thirst Relife Kit B" consisting of the same encouraging message, a cotton ball, and a 10 ml blister pack of distilled water.
Eligibility Criteria
You may qualify if:
- both sexes
- aged 18 years or older, with clear awareness and good cooperation
- who underwent colonoscopy with hospital bowel preparation
You may not qualify if:
- any risk of oral fluid aspiration
- swallowing disorders
- post-operative advanced head and neck surgeries
- advanced head and neck neoplasia, active oral diseases (oral mucosal lesions, stomatitis, among others)
- history of gastric surgeries (gastrectomized, upper gastrointestinal tract surgeries for obesity)
- use of GLP-1 analog medications and derivatives in the last 10 days according to hospital protocol (e.g., semaglutide, liraglutide, dulaglutide, tirzepatide...)
- history of dementia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Sírio Libanês
São Paulo, São Paulo, Brazil
Related Publications (1)
1. International Agency for Research on Cancer. GLOBOCAN 2020: estimated cancer incidence, mortality and prevalence worldwide in 2020. Lyon: IARC; 2021. 2. Islami F, Ward EM, Sung H, Cronin KA, Tangka FKL, Sherman RL, et al. Annual report to the nation on the status of cancer, part I: National cancer statistics. J Natl Cancer Inst. 2021. 3. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. 4. Winawer SJ, Zauber AG, O'Brien MJ, Ho MN, Gottlieb L, Sternberg SS, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps: the National Polyp Study Workgroup. N Engl J Med. 1993;328(13):901-6. 5. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy: the National Polyp Study Workgroup. N Engl J Med. 1993;329(27):1977-81. 6. Knudsen AB, Rutter CM, Peterse EFP, Lietz AP, Seguin CL, Meester RGS, et al. Colorectal cancer screening: an updated modeling study for the US Preventive Services Task Force. JAMA. 2021;325(19):1998-2011. doi:10.1001/jama.2021.5746. 7. Froehlich F, Wietlisbach V, Gonvers JJ, Burnand B, Vader JP. Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: the European Panel of Appropriateness of Gastrointestinal Endoscopy European multicenter study. Gastrointest Endosc. 2005;61(3):378-84. 8. Parente F, Marino B, Crosta C. Bowel preparation before colonoscopy in the era of mass screening for colorectal cancer: a practical approach. Dig Liver Dis. 2009;41(2):87-95. doi:10.1016/j.dld.2008.06.005. 9. Green SM, Leroy PL, Roback MG, Irwin MG, Andolfatto G, Babl FE, et al. An international multidisciplinary consensus statement on fasting before procedural sedation in adults and children. Anaesthesia. 2020;75(3):374-85. doi:10
BACKGROUND
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 7, 2026
First Posted
July 13, 2026
Study Start
December 8, 2025
Primary Completion (Estimated)
August 12, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
July 13, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share